-
US to take three-quarter stake in Armenia corridor
-
Semenyo an instant hit as Man City close on League Cup final
-
Trump warns of 'very strong action' if Iran hangs protesters
-
Marseille put nine past sixth-tier Bayeux in French Cup
-
Dortmund outclass Bremen to tighten grip on second spot
-
Shiffrin reasserts slalom domination ahead of Olympics with Flachau win
-
Fear vies with sorrow at funeral for Venezuelan political prisoner
-
Pittsburgh Steelers coach Tomlin resigns after 19 years: club
-
Russell eager to face Scotland team-mates when Bath play Edinburgh
-
Undav scores again as Stuttgart sink Frankfurt to go third
-
Fuming French farmers camp out in Paris despite government pledges
-
Man Utd appoint Carrick as manager to end of the season
-
Russia strikes power plant, kills four in Ukraine barrage
-
JPMorgan Chase reports mixed results as Dimon defends Fed chief
-
Vingegaard targets first Giro while thirsting for third Tour title
-
US pushes forward trade enclave over Armenia
-
Alpine release reserve driver Doohan ahead of F1 season
-
Toulouse's Ntamack out of crunch Champions Cup match against Sale
-
US takes aim at Muslim Brotherhood in Arab world
-
Gloucester sign Springbok World Cup-winner Kleyn
-
Trump tells Iranians 'help on its way' as crackdown toll soars
-
Iran threatens death penalty for 'rioters' as concern grows for protester
-
US ends protection for Somalis amid escalating migrant crackdown
-
Oil prices surge following Trump's Iran tariff threat
-
Fashion student, bodybuilder, footballer: the victims of Iran's crackdown
-
Trump tells Iranians to 'keep protesting', says 'help on its way'
-
Italian Olympians 'insulted' by torch relay snub
-
Davos braces for Trump's 'America First' onslaught
-
How AI 'deepfakes' became Elon Musk's latest scandal
-
Albania's waste-choked rivers worsen deadly floods
-
Cancelo rejoins Barca on loan from Al-Hilal
-
India hunts rampaging elephant that killed 20 people
-
Nuuk, Copenhagen mull Greenland independence in Trump's shadow
-
WHO says sugary drinks, alcohol getting cheaper, should be taxed more
-
Arteta urges Arsenal to learn from League Cup pain ahead of Chelsea semi
-
Davos elite, devotees of multilateralism, brace for Trump
-
Spanish star Julio Iglesias accused of sexual assault by two ex-employees
-
Trump's Iran tariff threat pushes oil price higher
-
US consumer inflation holds steady as affordability worries linger
-
Iran to press capital crime charges for 'rioters': prosecutors
-
Denmark, Greenland set for high-stake talks at White House
-
Iranian goes on trial in France ahead of possible prisoner swap
-
Cold winter and AI boom pushed US emissions increase in 2025
-
Hong Kong activist investor David Webb dies at 60
-
Try to be Mourinho and I'll fail: new Real Madrid coach Arbeloa
-
Vingegaard targets Giro d'Italia and Tour de France double
-
South Korean prosecutors demand death penalty for ex-leader Yoon
-
Iwobi hails Nigerian 'unity' with Super Eagles set for Morocco AFCON semi
-
Le Pen appeal trial opens with French presidential bid at stake
-
Iran ex-empress urges security forces to join protesters
US panel votes to end recommending all newborns receive hepatitis B vaccine
An advisory panel appointed by the Trump administration's vaccine-skeptic health secretary voted Friday to stop recommending that all newborns in the United States receive a hepatitis B vaccine.
The move to end the three-decade-old recommendation is the panel's latest contentious decision overturning long-standing medical advice since its overhaul by Health Secretary Robert F. Kennedy Jr., who has spent decades spreading anti-vaccine rhetoric.
US health authorities previously recommended all babies receive the first of three hepatitis B shots just after birth, mainly to prevent infections from mothers who unknowingly had the liver disease or had falsely tested negative.
The approach has virtually eradicated hepatitis B infections among young people in the United States.
Hepatitis B is a viral liver disease that can be transmitted by the mother during childbirth and puts those affected at high risk of death from cirrhosis or liver cancer.
After delaying the vote by a day, the panel eventually passed its new recommendation for "individual-based decision-making," in consultation with a health care provider, when children are born to mothers testing negatively for the disease.
The decision should "consider vaccine benefits, vaccine risks, and infection risks."
It also recommends that babies who are not vaccinated at birth wait at least two months to get the initial dose.
Under Kennedy, the Advisory Committee on Immunization Practices (ACIP) is now composed largely of figures criticized by the scientific community for lack of expertise or their promotion of vaccine-skeptic theories.
The vote was 8-3. Trump-appointed officials at the Centers for Disease Control and Prevention (CDC) are widely expected to formally adopt the recommendations at a later date.
Since 1991, US health officials have recommended the hepatitis B vaccine for newborns, as is done in countries including China and Australia and is recommended by the World Health Organization.
But several ACIP members have argued that Friday's decision aligns the US vaccination schedule with those of other economically developed countries such as France and Britain.
Medical experts say such a change is risky in the United States, pointing to shortcomings in maternal screening, with delays likely to cause a drop in vaccination rates in a country where access to health care can be complicated.
"This irresponsible and purposely misleading guidance will lead to more hepatitis B infections in infants and children," American Academy of Pediatrics President Susan J. Kressly said in a statement.
The repercussions of the ACIP's vaccine recommendations are broad because federal guidelines often dictate whether vaccines are paid for by health insurance companies in the United States, where a vaccine can cost hundreds of dollars.
On Friday, the panel is set to begin a broader review of the childhood vaccination schedule and the composition of vaccines.
But the committee's influence is waning amid withering criticism from the US scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.
Some in Trump's own Republican party have also pushed back against the ACIP's actions, including Louisiana Senator Bill Cassidy.
Cassidy, a medical doctor who provided a key vote to allow Kennedy's nomination to succeed, condemned the ACIP's decision, noting the original recommendation was "NOT a mandate" to get the jab.
CDC officials "should not sign these new recommendations and instead retain the current, evidence-based approach," he said on X.
Ahead of the vote, Dr. Cody Meissner, one of the few dissenting voices on the advisory committee, urged his colleagues not to change the current recommendations.
"Do no harm is a moral imperative. We are doing harm by changing this wording," he warned.
X.Brito--PC